FIELD: medicine.
SUBSTANCE: method involves administration of thioctic acid at a dose of 600 mg/day inwards on an empty stomach 30 minutes before eating, 1-3 times a day for at least 3 months.
EFFECT: use of the invention allows to improve the cognitive function of patients with initial symptoms of moderate cognitive reduction.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF BLOOD SUGAR LEVEL AND TREATMENT OF PATIENTS WITH TYPE TWO DIABETES MELLITUS AND COGNITIVE DEFECTS | 2011 |
|
RU2467749C1 |
| ACTIVE INGREDIENT OF MEDICINAL AGENT, MEDICINAL AGENT, PHARMACEUTICAL CONPOSITION AND METHOD OF DEMENT SYNDROME TREATMENT | 2007 |
|
RU2327480C1 |
| MEDICINAL AGENT, A PHARMACEUTICAL COMPOSITION, AN ACTIVE INGREDIENT OF THE PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATING COGNITIVE DISORDERS IN THE PATIENTS SUFFERING ACUTE MYOCARDIAL INFARCTION | 2018 |
|
RU2702127C1 |
| METHOD FOR CORRECTING COGNITIVE DISORDERS IN PATIENTS WITH ARTERIAL HYPERTENSION ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2014 |
|
RU2555334C1 |
| DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS | 2005 |
|
RU2394570C2 |
| MONOAMINOOXIDASE INHIBITORS, THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2366430C2 |
| DRUG FOR GASTROINTESTINAL TRACT AND HEPATOBILIARY SYSTEM DISEASES TREATMENT AND PREVENTING RECRUDESCENCES | 2017 |
|
RU2651711C1 |
| PHARMACEUTICAL COMPOSITIONS OF IPIDACRINE AND USING THEM FOR TREATING AND PREVENTING SOLUTION OF CONTINUITY | 2012 |
|
RU2512743C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC BRAIN ISCHEMIA | 2021 |
|
RU2752065C1 |
| INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME | 2013 |
|
RU2667058C2 |
